Received Mar 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z015169 | — |
No additional AE; administration of the improperly stored vaccine; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 23-Feb-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) powder and solvent for solution for injection (lot #Z015169, expiration date: 29-Sep-2027), 0.5 mL administered as prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot #2190800, expiration date: 31-Jul-2027). The vaccine was administered after being improperly stored (Product storage error). No additional adverse event. At the reporting time, the outcome of the events was unknown. The action taken with the suspect products was not applicable.
MERCK STERILE DILUENT